Search Results - "HARARI, M"

Well-Being in Social Interactions: Examining Personality-Situation Dynamics in Face-to-Face and Computer-Mediated Communication by Kroencke, Lara, Harari, Gabriella M., Back, Mitja D., Wagner, Jenny

“…Decades of research show that people's social lives are linked to their well-being. Yet, research on the relationship between social interactions and…”
Get full text

Understanding resistance to EGFR inhibitors-impact on future treatment strategies by Dunn, Emily F, Harari, Paul M, Wheeler, Deric L

“…EGFR is one of the most studied targets in oncology, and several inhibitors have shown promising results in selected patient populations. However, intrinsic…”
Get full text

The potential of generative AI for personalized persuasion at scale by Matz, S. C., Teeny, J. D., Vaid, S. S., Peters, H., Harari, G. M., Cerf, M.

“…Matching the language or content of a message to the psychological profile of its recipient (known as “personalized persuasion”) is widely considered to be one…”
Get full text

p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma by Chung, Christine H, Zhang, Qiang, Kong, Christina S, Harris, Jonathan, Fertig, Elana J, Harari, Paul M, Wang, Dian, Redmond, Kevin P, Shenouda, George, Trotti, Andy, Raben, David, Gillison, Maura L, Jordan, Richard C, Le, Quynh-Thu

“…Although p16 protein expression, a surrogate marker of oncogenic human papillomavirus (HPV) infection, is recognized as a prognostic marker in oropharyngeal…”
Get full text

Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members by Wheeler, D L, Huang, S, Kruser, T J, Nechrebecki, M M, Armstrong, E A, Benavente, S, Gondi, V, Hsu, K-T, Harari, P M

“…The epidermal growth factor receptor (EGFR) is a central regulator of proliferation and progression in human cancers. Five EGFR inhibitors, two monoclonal…”
Get full text

Epidermal growth factor receptor inhibition strategies in oncology by Harari, P M

“…Molecular targeting strategies for cancer therapy are distinct from conventional chemotherapy and radiotherapy in their potential to provide increased tumor…”
Get full text

Enhanced Radiation Sensitivity in HPV-Positive Head and Neck Cancer by KIMPLE, Randall J, SMITH, Molly A, LAMBERT, Paul F, HARARI, Paul M, BLITZER, Grace C, TORRES, Alexandra D, MARTIN, Joshua A, YANG, Robert Z, PEET, Chimera R, LORENZ, Laurel D, NICKEL, Kwangok P, KLINGELHUTZ, Aloysius J

“…Patients with human papillomavirus (HPV+)-associated head and neck cancer (HNC) show significantly improved survival outcome compared with those with…”
Get full text

Postoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234 by HARARI, Paul M, HARRIS, Jonathan, STRAUBE, William, QIANG ZHANG, KIAN ANG, KIES, Merrill S, MYERS, Jeffrey N, JORDAN, Richard C, GILLISON, Maura L, FOOTE, Robert L, MACHTAY, Mitchell, ROTMAN, Marvin, KHUNTIA, Deepak

“…To report results of a randomized phase II trial (Radiation Therapy Oncology Group RTOG-0234) examining concurrent chemoradiotherapy and cetuximab in the…”
Get full text

Multi-Institutional Trial of Accelerated Hypofractionated Intensity-Modulated Radiation Therapy for Early-Stage Oropharyngeal Cancer (RTOG 00-22) by Eisbruch, Avraham, M.D, Harris, Jonathan, M.S, Garden, Adam S., M.D, Chao, Clifford K.S., M.D, Straube, William, Ph.D, Harari, Paul M., M.D, Sanguineti, Giuseppe, M.D, Jones, Christopher U., M.D, Bosch, Walter R., D.Sc, Ang, K. Kian, M.D., Ph.D

“…Purpose To assess the results of a multi-institutional study of intensity-modulated radiation therapy (IMRT) for early oropharyngeal cancer. Patients and…”
Get full text

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck by Bonner, James A, Harari, Paul M, Giralt, Jordi, Azarnia, Nozar, Shin, Dong M, Cohen, Roger B, Jones, Christopher U, Sur, Ranjan, Raben, David, Jassem, Jacek, Ove, Roger, Kies, Merrill S, Baselga, Jose, Youssoufian, Hagop, Amellal, Nadia, Rowinsky, Eric K, Ang, K. Kian

“…Treatment of advanced locoregional head and neck cancer with high-dose radiotherapy plus cetuximab was superior to radiotherapy alone in improving local…”
Get full text

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival by Bonner, James A, Prof, Harari, Paul M, Prof, Giralt, Jordi, Prof, Cohen, Roger B, Prof, Jones, Christopher U, MD, Sur, Ranjan K, Prof, Raben, David, Prof, Baselga, Jose, Prof, Spencer, Sharon A, Prof, Zhu, Junming, PhD, Youssoufian, Hagop, MD, Rowinsky, Eric K, MD, Ang, K Kian, Prof

“…Summary Background Previous results from our phase 3 randomised trial showed that adding cetuximab to primary radiotherapy increased overall survival in…”
Get full text

Radiation Dose Escalation in Esophageal Cancer Revisited: Contemporary Analysis of the National Cancer Data Base, 2004-2012 by Brower, Jeffrey V., MD PhD, Chen, Shuai, PhD, Bassetti, Michael F., MD PhD, Yu, Menggang, PhD, Harari, Paul M., MD, Ritter, Mark A., MD PhD, Baschnagel, Andrew M., MD

“…Abstract Purpose To evaluate the impact of radiation dose escalation on overall survival (OS) for patients with non-metastatic esophageal cancer treated with…”
Get full text

Biology of Interactions: Antiepidermal Growth Factor Receptor Agents by Harari, Paul M, Allen, Gregory W, Bonner, James A

“…Epidermal growth factor receptor (EGFR) signaling inhibition represents a highly promising arena for the application of molecularly targeted cancer therapies…”
Get full text

Evaluating voice samples as a potential source of information about personality by Marrero, Zachariah N.K., Gosling, Samuel D., Pennebaker, James W., Harari, Gabriella M.

“…Speech is a powerful medium through which a variety of psychologically relevant phenomena are expressed. Here we take a first step in evaluating the potential…”
Get full text

Variation in social media sensitivity across people and contexts by Vaid, Sumer S., Kroencke, Lara, Roshanaei, Mahnaz, Talaifar, Sanaz, Hancock, Jeffrey T., Back, Mitja D., Gosling, Samuel D., Ram, Nilam, Harari, Gabriella M.

“…Social media impacts people’s wellbeing in different ways, but relatively little is known about why this is the case. Here we introduce the construct of…”
Get full text

p53 Modulates Acquired Resistance to EGFR Inhibitors and Radiation by HUANG, Shyhmin, BENAVENTE, Sergio, ARMSTRONG, Eric A, CHUNRONG LI, WHEELER, Deric L, HARARI, Paul M

“…There is presently great interest in mechanisms of acquired resistance to epidermal growth factor receptor (EGFR) inhibitors that are now being used widely in…”
Get full text

A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy by Rosenberg, Stephen A., MD, Henke, Lauren E., MD, Shaverdian, Narek, MD, Mittauer, Kathryn, PhD, Wojcieszynski, Andrzej P., MD, Hullett, Craig R., MD, PhD, Kamrava, Mitchell, MD, Lamb, James, PhD, Cao, Minsong, Green, Olga L., PhD, Kashani, Rojano, PhD, Paliwal, Bhudatt, PhD, Bayouth, John, PhD, Harari, Paul M., MD, Olsen, Jeffrey R., MD, Lee, Percy, MD, Parikh, Parag J., MD, Bassetti, Michael, MD, PhD

“…Abstract Purpose Daily magnetic resonance (MR)–guided radiation has the potential to improve stereotactic body radiation therapy (SBRT) for tumors of the…”
Get full text

Small cell carcinoma of the head and neck: An analysis of the National Cancer Database by Pointer, Kelli B, Ko, Huaising C, Brower, Jeffrey V, Witek, Matthew E, Kimple, Randall J, Lloyd, Ricardo V, Harari, Paul M, Baschnagel, Andrew M

“…Highlights • Small cell carcinoma of the head and neck is a rare and aggressive disease. • Larynx, nasal cavity and paranasal sinuses are the most common…”
Get full text

Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma by Hatakeyama, Hiromitsu, Cheng, Haixia, Wirth, Pamela, Counsell, Ashley, Marcrom, Samuel R, Wood, Carey Burton, Pohlmann, Paula R, Gilbert, Jill, Murphy, Barbara, Yarbrough, Wendell G, Wheeler, Deric L, Harari, Paul M, Guo, Yan, Shyr, Yu, Slebos, Robbert J, Chung, Christine H

“…We hypothesized that chronic inhibition of epidermal growth factor receptor (EGFR) by cetuximab, a monoclonal anti-EGFR antibody, induces up-regulation of its…”
Get full text

Targeting AKT/PKB to improve treatment outcomes for solid tumors by Iida, M, Harari, P M, Wheeler, D L, Toulany, M

“…The serine/threonine kinase AKT, also known as protein kinase B (PKB), is the major substrate to phosphoinositide 3-kinase (PI3K) and consists of three…”
Get more information